(Download: Custom Cycle Development in PDF by Medistri)
Engineering Product-Specific Sterilization Processes for Medical Devices and Pharmaceutical Applications
Sterilization processes are often associated with standardized cycle recipes designed to treat a broad range of healthcare products. In practice, however, many medical devices, pharmaceutical components, and packaging systems require sterilization conditions that cannot be reliably addressed using predefined cycle parameters.
Products may present complex geometries, multilayer packaging systems, sensitive materials, or packaging configurations that influence gas penetration and process kinetics. Under these circumstances, sterilization parameters must be specifically developed and characterized to ensure that the required Sterility Assurance Level (SAL) is achieved while preserving product functionality and packaging integrity.
Custom cycle development provides a structured engineering framework to define sterilization parameters adapted to a specific device, packaging configuration, and load structure. Through controlled pre-testing, environmental characterization, and microbiological analysis, sterilization processes can be scientifically designed to meet regulatory expectations while maintaining operational reliability.
Medistri supports custom cycle development across its dual-site sterilization infrastructure in Switzerland and Hungary, integrating sterilization engineering with in-house laboratory services to support medical device and pharmaceutical manufacturers across development, market introduction, and industrial production phases.
Why Custom Cycle Development Is Often Required
Standard sterilization cycles are typically developed to treat a wide range of products with relatively similar material properties and packaging structures. However, many healthcare products introduce variables that significantly affect sterilization performance.
Examples include:
- Complex device geometries with internal cavities or lumens
- Multilayer sterile barrier systems that influence gas diffusion
- Sensitive polymers or materials that may degrade under aggressive sterilization conditions
- High-density product loads that affect gas or steam penetration
- Novel pharmaceutical packaging configurations
In these situations, applying a standard sterilization cycle may create one of two risks:
- Insufficient sterilization performance due to inadequate gas penetration
- Product or packaging degradation caused by overly aggressive sterilization parameters
Custom cycle development addresses this challenge by engineering sterilization conditions tailored to the specific product configuration while maintaining compliance with international standards such as:
- ISO 11135 — EO Sterilization
- ISO 17665 — Steam Sterilization
- ISO 11737 — Bioburden and Sterility Testing
- ISO 10993-7 — Residual Ethylene Oxide
The Role of Pre-Testing in Cycle Development
Custom cycle development typically begins with a pre-testing phase, during which exploratory sterilization cycles are performed to characterize how the product interacts with the sterilization environment.
These development cycles often use instrumented loads containing environmental sensors and microbiological indicators to generate early data on sterilization performance. The objectives of pre-testing generally include:
- Defining preliminary sterilization parameters
- Evaluating gas penetration within the product configuration
- Identifying potential worst-case product locations
- Characterizing temperature, humidity, and exposure conditions
- Determining process sensitivity to parameter variation
- Conducting Product Functional Testing
Instrumented development cycles may involve extensive sensor placement throughout the load, allowing engineers to monitor environmental conditions across multiple locations within the chamber. These early development studies provide critical insight into the behavior of the sterilization process before formal validation begins.
Comparative Testing and Worst-Case Identification
When multiple product variants or packaging configurations are involved, identifying the worst-case configurationbecomes a critical step in cycle development.
Comparative pre-testing may therefore be conducted using several product configurations exposed to identical sterilization conditions.
Biological indicators placed within each product configuration provide microbiological evidence of sterilization performance.
During early development cycles, enumeration techniques may be used to quantify microbial survival following exposure to the sterilization process. This approach enables engineers to measure the degree of microbial reduction achieved under specific process conditions. Comparative testing supports:
- Identification of the most difficult-to-sterilize configuration
- Selection of the reference configuration for validation
- Definition of robust cycle parameters
By validating the sterilization cycle against the worst-case product configuration, manufacturers can ensure that the process remains effective across the entire product family.
Environmental Mapping of the Sterilization Environment
Accurate characterization of environmental conditions inside the sterilization chamber is a key component of custom cycle development. Instrumented mapping studies may include dozens of sensors distributed across the load, allowing engineers to monitor:
- Temperature distribution
- Relative humidity
- Pressure profiles
- Exposure conditions
Environmental mapping supports several important objectives:
- Identifying cold spots or areas with limited penetration
- Confirming uniform exposure conditions
- Verifying process consistency across load configurations
- Supporting the definition of operational process windows
By combining environmental measurements with microbiological results, sterilization engineers can progressively refine cycle parameters to achieve consistent sterilization performance.
The Role of Biological Indicators in Cycle Development
Biological indicators play a central role in the scientific development of sterilization cycles. During early development phases, enumeration-based studies may be used to measure the survival of microbial spores following exposure to the sterilization process. This provides quantitative data on sterilization lethality under specific process conditions. As cycle parameters are refined, development cycles may transition to incubation-based testing, which confirms the absence of microbial growth following sterilization exposure. These microbiological methods provide:
- Evidence of microbial inactivation performance
- Data supporting cycle parameter optimization
- Technical justification for subsequent validation studies
The integration of microbiological analysis with environmental monitoring forms the scientific basis of custom sterilization cycle development.
The Influence of Packaging and Sealing Systems
Sterile barrier systems and packaging materials can significantly influence sterilization performance.
Packaging permeability affects how gas interacts with the product during the sterilization process. Sealing methods may also influence gas or steam penetration, particularly when multilayer packaging systems are used. As a result, packaging considerations are often integrated into cycle development studies. Comparative testing may evaluate:
- Different packaging materials
- Alternative sealing technologies
- Various load configurations
These studies ensure that sterilization conditions remain effective while maintaining packaging integrity and sterile barrier performance.
Laboratory testing may also be conducted to evaluate:
- Sterile barrier integrity
- Packaging seal strength
- transport simulation compatibility
Integration with Laboratory Testing
Custom cycle development is typically supported by complementary laboratory analyses that provide additional evidence of product safety and process performance. Integrated laboratory services may include:
- Bioburden testing (ISO 11737-1)
- Sterility testing (ISO 11737-2)
- Bacterial endotoxin testing (LAL)
- Residual analysis (ISO 10993-7)
- Packaging integrity testing
- Functional Testing
Medistri integrates sterilization engineering with laboratory services performed within its Swiss laboratory infrastructure, enabling coordinated testing during both development and validation phases.
This integrated approach allows manufacturers to generate the microbiological and analytical evidence required for regulatory submissions in EU and US markets.
Transitioning from Development to Validation
Once sterilization parameters have been defined through pre-testing and environmental characterization, the process transitions to formal sterilization validation. Validation activities typically include:
- Microbiological challenge studies
- Minimum load validation
- Maximum load validation
- Back up Chamber Validation
- Routine process monitoring definition
These studies confirm that the sterilization cycle consistently achieves the required sterility assurance level under defined operating conditions.
Following successful validation, the cycle becomes part of a controlled routine sterilization process.
Medistri performs sterilization operations across its facilities in Switzerland and Hungary, collectively processing more than 90,000 pallets of healthcare products annually, supporting manufacturers from early product development through commercial production.
Differences in materials, device design, packaging systems, and load configurations mean that sterilization parameters cannot simply be transferred from one product to another without evaluation.
Through structured pre-testing, environmental characterization, microbiological analysis, and validation studies, custom cycle development ensures that sterilization processes remain:
- Scientifically justified
- Operationally robust
- Fully aligned with international regulatory standards
This engineering-driven approach allows manufacturers to introduce new healthcare products while maintaining the highest standards of patient safety and regulatory compliance.
To learn more about Medistri’s Sterilization Services, please visit our website here or contact us at contact@medistri.com.
– The Medistri Team
#Medistri
Medistri is Europe's leading independent contract sterilization company, founded in 2006 and headquartered in the heart of Switzerland. We are a global player providing essential infrastructure that powers healthcare innovation worldwide.
We serve customers of all sizes, from startups, university projects, and research institutes to Fortune 500 corporations, across Medical Devices, Pharmaceutical Packaging, and Biotech.
Medistri supports products at every stage of the lifecycle: pre-clinical development, go-to-market, and full industrialization.
Our fully integrated, end-to-end in-house solution allows our customers to focus on what matters most: engineering, innovation, and development, while we manage the critical back-end processes.
Our synchronized departments work together to provide a complete stack of services:
- Contract Sterilization & Validation Services
- Contract Laboratory Services
- Contract Manufacturing Services
- Logistics Services
- Consulting Services
We help you accelerate time-to-market, reduce barriers to scale, and deliver safer, more sustainable healthcare solutions to patients around the world.
Medistri Solutions for Products in Go-to-Market Phase
In the go-to-market phase, precision and speed are critical to demonstrate regulatory readiness, secure market access, and launch with confidence.
Medistri acts as your trusted, fully integrated infrastructure partner, providing a comprehensive suite of in-house Solutions tailored to support validation, submission, and commercial readiness.
Our solutions include packaging validation, shelf-life studies, cleaning & reprocessing validation, sterilization validation, custom cycle development, laboratory method validation, support-to-submission services, post-validation training, EO-free supply chain validation, CE Mark pathway consulting, and MDR transition consulting.
By managing the entire validation and compliance process under one roof in our Swiss facility, Medistri eliminates multi-vendor complexity, accelerates regulatory timelines, ensures consistent data quality and traceability, and allows your team to focus on strategic market entry and commercial execution.
Enabling a smooth, compliant transition from development to successful product launch.
Frequently Asked Questions
1. What is custom sterilization cycle development?
Custom sterilization cycle development is the process of designing sterilization parameters specifically adapted to a particular product, packaging configuration, and load structure. It ensures that the sterilization process achieves the required sterility assurance level while maintaining product and packaging integrity.
2. Why are standard sterilization cycles not suitable for all healthcare products?
Medical devices and pharmaceutical products can vary widely in materials, geometry, and packaging systems. These differences influence how gas penetrate the product and interact with its components, making product-specific cycle parameters necessary in many cases.
3. How does pre-testing support sterilization cycle development?
Pre-testing uses short development cycles with instrumented loads and biological indicators to evaluate how sterilization conditions affect the product and packaging system. This stage helps define preliminary parameters, assess gas penetration, and identify potential worst-case locations within the load.
4. When is the worst-case product configuration identified during cycle development?
Worst-case identification typically occurs during comparative testing of multiple product variants or packaging configurations. The configuration that presents the greatest challenge to sterilization performance becomes the reference for subsequent development and validation studies.
5. How does Medistri support manufacturers during custom cycle development?
Medistri conducts structured pre-testing, environmental chamber mapping, microbiological assessments, and validation studies to establish product-specific sterilization parameters. By combining engineering analysis with laboratory testing, Medistri helps ensure that sterilization processes are scientifically justified, robust, and compliant with regulatory expectations.